121 related articles for article (PubMed ID: 25167375)
1. Pharmacokinetics and pharmacodynamics of antibacterial and antifungal agents in adult patients with thermal injury: a review of current literature.
Ortwine JK; Pogue JM; Faris J
J Burn Care Res; 2015; 36(2):e72-84. PubMed ID: 25167375
[TBL] [Abstract][Full Text] [Related]
2. Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients.
Blanchet B; Jullien V; Vinsonneau C; Tod M
Clin Pharmacokinet; 2008; 47(10):635-54. PubMed ID: 18783295
[TBL] [Abstract][Full Text] [Related]
3. Gap analysis of pharmacokinetics and pharmacodynamics in burn patients: a review.
Steele AN; Grimsrud KN; Sen S; Palmieri TL; Greenhalgh DG; Tran NK
J Burn Care Res; 2015; 36(3):e194-211. PubMed ID: 25942648
[TBL] [Abstract][Full Text] [Related]
4. Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury.
Cota JM; FakhriRavari A; Rowan MP; Chung KK; Murray CK; Akers KS
Clin Ther; 2016 Sep; 38(9):2016-31. PubMed ID: 27586127
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and Pharmacodynamics of Antimicrobial Agents in Burn Patients.
Pruskowski KA
Surg Infect (Larchmt); 2021 Feb; 22(1):77-82. PubMed ID: 33164665
[No Abstract] [Full Text] [Related]
6. Clinical pharmacokinetics in patients with burns.
Jaehde U; Sörgel F
Clin Pharmacokinet; 1995 Jul; 29(1):15-28. PubMed ID: 7586895
[TBL] [Abstract][Full Text] [Related]
7. [Antimicrobial treatment in burn injury patients].
Trupkovic T; Gille J; Fischer H; Kleinschmidt S
Anaesthesist; 2012 Mar; 61(3):249-51, 254-6, 258. PubMed ID: 22430556
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.
De Paepe P; Belpaire FM; Buylaert WA
Clin Pharmacokinet; 2002; 41(14):1135-51. PubMed ID: 12405864
[TBL] [Abstract][Full Text] [Related]
9. Use of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients.
Buck ML; Reed MD
Clin Pharm; 1991 Jan; 10(1):32-48. PubMed ID: 1825627
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial Agent Dosing in Infants.
Johnson JK; Laughon MM
Clin Ther; 2016 Sep; 38(9):1948-60. PubMed ID: 27473383
[TBL] [Abstract][Full Text] [Related]
11. Review of pharmacokinetics and pharmacodynamics of antimicrobial agents.
Estes L
Mayo Clin Proc; 1998 Nov; 73(11):1114-22. PubMed ID: 9818049
[TBL] [Abstract][Full Text] [Related]
12. Antifungal activity of nonantifungal drugs.
Afeltra J; Verweij PE
Eur J Clin Microbiol Infect Dis; 2003 Jul; 22(7):397-407. PubMed ID: 12884072
[TBL] [Abstract][Full Text] [Related]
13. The effects of major burn related pathophysiological changes on the pharmacokinetics and pharmacodynamics of drug use: An appraisal utilizing antibiotics.
Udy AA; Roberts JA; Lipman J; Blot S
Adv Drug Deliv Rev; 2018 Jan; 123():65-74. PubMed ID: 28964882
[TBL] [Abstract][Full Text] [Related]
14. Antifungal prophylaxis in pediatric patients undergoing therapy for cancer: drugs and dosing.
Lehrnbecher T
Curr Opin Infect Dis; 2015 Dec; 28(6):523-31. PubMed ID: 26381996
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of antibiotics in burn patients.
Weinbren MJ
J Antimicrob Chemother; 1999 Sep; 44(3):319-27. PubMed ID: 10511398
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetic evaluation of linezolid in patients with major thermal injuries].
Le Floch R; Arnould JF; Vinsonneau C; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Lovering AM
Pathol Biol (Paris); 2010 Apr; 58(2):e27-31. PubMed ID: 19854590
[TBL] [Abstract][Full Text] [Related]
17. Vecuronium pharmacokinetics in patients with major burns.
Vega-Villa KR; Kaneda K; Yamashita S; Woo S; Han TH
Br J Anaesth; 2014 Feb; 112(2):304-10. PubMed ID: 24067332
[TBL] [Abstract][Full Text] [Related]
18. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
19. Bibliography. Current world literature. Antimicrobial agents: bacterial/fungal.
Curr Opin Infect Dis; 2002 Dec; 15(6):615-21. PubMed ID: 12825593
[No Abstract] [Full Text] [Related]
20. Antifungal pharmacokinetics and pharmacodynamics: understanding the implications for antifungal drug resistance.
Andes D
Drug Resist Updat; 2004 Jun; 7(3):185-94. PubMed ID: 15296860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
